S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › CLIME-B › Research report
← CLIME-B page
XStocksXray
Market X-Ray report · 19 October 2026

Climeon AB (publ) (CLIME-B)

Stockholm Exchange · Sweden · prices in SEK · close of 19 Oct 2026

Key indicators

Last closeSEK 2.700
52-week range1.940 – 4.880
Return, 1 month / 3 months−5.3% / +6.3%
Return, 1 year / 3 years−24.6% / −83.2%
TrendAbove 200-day, below 50-day
RSI (14)42
Volatility (1 year)66.9%
Worst drawdown (1 year)-50.5%
Average daily value traded0.16M SEK
Dividend yield–

Market X-Ray price-based

50/ 100 · High confidence · ahead of 49% of stocks on this exchange
Trend59
Momentum66
Stability (higher is calmer)34
Liquidity35
Income–

Five-year price chart navy: price · brown: 200-day average

-4.5926.1256.8387.541182021-102023-012024-042025-072026-10

About the company

Climeon AB develops and supplies equipment that turns low-temperature waste heat into electricity. Its heat power modules are used aboard ships and in industrial plants, where they recover heat from engines and processes to generate clean power on site. The company is based in Sweden and serves customers in the marine and industrial energy markets, offering modular units that can be installed in new builds or added to existing installations.

On this site Climeon AB (publ) appears as a stock on the Stockholm Exchange (Sweden), code CLIME-B, with prices in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Climeon AB (publ) (CLIME-B) trades on the Stockholm Exchange in Sweden. It last closed at SEK 2.700 on 19 October 2026.

Its price-based Market X-Ray is 50 out of 100 (a fair price profile), ranking 461 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 24.6% and over the last three months it rose 6.3%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Climeon AB (publ) (CLIME-B)

The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange

Lens and metricValueScoreReading
Trend59 · FairMixed trend against its averages.
Above 200-day average0.1%
From 52-week high-36.0%
Momentum66 · FairTypical recent returns for this exchange.
3-month return6.3%
6-month return28.0%
12-month return, skipping the last month-20.4%
Stability (higher is calmer)34 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)66.9%
Worst drawdown, 1 year (smaller is calmer)-50.5%
Liquidity35 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.16M SEK
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−3.2%
1 month−5.3%
3 months+6.3%
6 months+28.0%
1 year−24.6%
3 years−83.2%
5 years–

Signals

50-day / 200-day average2.863 / 2.698
Golden / death cross (60 days)Golden, 25 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.155

Technical summary

DailyStrongly bearish1 bullish · 4 neutral · 11 bearish
WeeklyStrongly bearish1 bullish · 1 neutral · 10 bearish
MonthlyStrongly bearish1 bullish · 1 neutral · 6 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026